Encequidar mesylate
CAS: 849675-87-2
Ref. 3D-ZIB67587
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Encequidar mesylate is a quinoline derivative that has shown cancer-resistance properties. It has been shown to inhibit the uptake of intracellular chloride, which is necessary for the development of cancerous cells. Encequidar mesylate has also been shown to inhibit wild-type mouse tumor growth in vivo and in vitro. Encequidar mesylate is an orally administered drug that can be used in animals as well as humans. The drug is currently being evaluated for its ability to prevent metastasis and to reduce tumor size in animals with human cancers.
Chemical properties
Technical inquiry about: 3D-ZIB67587 Encequidar mesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
